

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.62054196 |
| 2 | protein maturation by protein folding (GO:0022417) | 5.23435674 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.75294793 |
| 4 | DNA deamination (GO:0045006) | 4.69748883 |
| 5 | respiratory electron transport chain (GO:0022904) | 4.66965765 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.60091091 |
| 7 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.55933805 |
| 8 | electron transport chain (GO:0022900) | 4.54477386 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 4.48194285 |
| 10 | chaperone-mediated protein transport (GO:0072321) | 4.19375837 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.15379177 |
| 12 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.15379177 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 4.12159682 |
| 14 | proteasome assembly (GO:0043248) | 4.11320919 |
| 15 | viral transcription (GO:0019083) | 4.09790430 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.06319876 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.06319876 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 4.03031765 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.03031765 |
| 20 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.96974639 |
| 21 | translational termination (GO:0006415) | 3.93259872 |
| 22 | sequestering of actin monomers (GO:0042989) | 3.79267019 |
| 23 | aldehyde catabolic process (GO:0046185) | 3.72802807 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 3.72385129 |
| 25 | protein neddylation (GO:0045116) | 3.71397398 |
| 26 | translational elongation (GO:0006414) | 3.70720779 |
| 27 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.65378647 |
| 28 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.65378647 |
| 29 | oxaloacetate metabolic process (GO:0006107) | 3.65161923 |
| 30 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.62612522 |
| 31 | tricarboxylic acid cycle (GO:0006099) | 3.60852797 |
| 32 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.60106396 |
| 33 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.56879145 |
| 34 | NADH dehydrogenase complex assembly (GO:0010257) | 3.56879145 |
| 35 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.56879145 |
| 36 | cotranslational protein targeting to membrane (GO:0006613) | 3.54162572 |
| 37 | protein targeting to ER (GO:0045047) | 3.52668439 |
| 38 | mitotic nuclear envelope reassembly (GO:0007084) | 3.48791784 |
| 39 | nuclear envelope reassembly (GO:0031468) | 3.48791784 |
| 40 | establishment of protein localization to mitochondrion (GO:0072655) | 3.41533413 |
| 41 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.40846877 |
| 42 | protein localization to endoplasmic reticulum (GO:0070972) | 3.40398580 |
| 43 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.31331350 |
| 44 | GTP biosynthetic process (GO:0006183) | 3.29560994 |
| 45 | gluconeogenesis (GO:0006094) | 3.29529300 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 3.26789162 |
| 47 | positive regulation of TOR signaling (GO:0032008) | 3.25012009 |
| 48 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.24470287 |
| 49 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.23314777 |
| 50 | monosaccharide biosynthetic process (GO:0046364) | 3.22338943 |
| 51 | protein localization to mitochondrion (GO:0070585) | 3.20308899 |
| 52 | protein insertion into membrane (GO:0051205) | 3.19419016 |
| 53 | pentose metabolic process (GO:0019321) | 3.19290073 |
| 54 | nucleobase biosynthetic process (GO:0046112) | 3.17367540 |
| 55 | translational initiation (GO:0006413) | 3.16170866 |
| 56 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.15980661 |
| 57 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.15980661 |
| 58 | cellular protein complex disassembly (GO:0043624) | 3.15506556 |
| 59 | viral life cycle (GO:0019058) | 3.15151852 |
| 60 | regulation of cellular amine metabolic process (GO:0033238) | 3.14919017 |
| 61 | hexose biosynthetic process (GO:0019319) | 3.13582812 |
| 62 | folic acid metabolic process (GO:0046655) | 3.12514538 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 3.12166114 |
| 64 | regulation of mitochondrial translation (GO:0070129) | 3.11985890 |
| 65 | regulation of oxidative phosphorylation (GO:0002082) | 3.11707812 |
| 66 | UTP biosynthetic process (GO:0006228) | 3.11191023 |
| 67 | purine nucleobase biosynthetic process (GO:0009113) | 3.09568193 |
| 68 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.09224251 |
| 69 | oxidative phosphorylation (GO:0006119) | 3.08251949 |
| 70 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.06847996 |
| 71 | ATP biosynthetic process (GO:0006754) | 3.05296180 |
| 72 | ribosomal large subunit biogenesis (GO:0042273) | 3.04400807 |
| 73 | glycine metabolic process (GO:0006544) | 3.04293946 |
| 74 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.03940935 |
| 75 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.02368913 |
| 76 | heme biosynthetic process (GO:0006783) | 3.01978020 |
| 77 | hydrogen ion transmembrane transport (GO:1902600) | 2.99689555 |
| 78 | UTP metabolic process (GO:0046051) | 2.99480190 |
| 79 | translation (GO:0006412) | 2.99171119 |
| 80 | mitochondrial transport (GO:0006839) | 2.98934452 |
| 81 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.97097612 |
| 82 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.96500100 |
| 83 | regulation of superoxide anion generation (GO:0032928) | 2.94664301 |
| 84 | galactose catabolic process (GO:0019388) | 2.94641881 |
| 85 | deoxyribonucleotide catabolic process (GO:0009264) | 2.93449047 |
| 86 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.93230513 |
| 87 | regulation of mitochondrial membrane potential (GO:0051881) | 2.93045832 |
| 88 | maturation of SSU-rRNA (GO:0030490) | 2.92783023 |
| 89 | proline biosynthetic process (GO:0006561) | 2.91437031 |
| 90 | transferrin transport (GO:0033572) | 2.90946473 |
| 91 | establishment of viral latency (GO:0019043) | 2.89053505 |
| 92 | L-methionine salvage (GO:0071267) | 2.89018666 |
| 93 | L-methionine biosynthetic process (GO:0071265) | 2.89018666 |
| 94 | amino acid salvage (GO:0043102) | 2.89018666 |
| 95 | base-excision repair, AP site formation (GO:0006285) | 2.86781776 |
| 96 | heme metabolic process (GO:0042168) | 2.86455352 |
| 97 | hydrogen peroxide metabolic process (GO:0042743) | 2.86320781 |
| 98 | sulfur amino acid catabolic process (GO:0000098) | 2.84773946 |
| 99 | phospholipid efflux (GO:0033700) | 2.83740286 |
| 100 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81833424 |
| 101 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.80623507 |
| 102 | CTP biosynthetic process (GO:0006241) | 2.80317838 |
| 103 | CTP metabolic process (GO:0046036) | 2.80317838 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80297481 |
| 105 | nucleoside salvage (GO:0043174) | 2.77597108 |
| 106 | heart contraction (GO:0060047) | 2.75366594 |
| 107 | heart process (GO:0003015) | 2.75366594 |
| 108 | formation of translation preinitiation complex (GO:0001731) | 2.75202764 |
| 109 | termination of RNA polymerase III transcription (GO:0006386) | 2.74572971 |
| 110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.74572971 |
| 111 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.74127246 |
| 112 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.73853432 |
| 113 | hydrogen peroxide catabolic process (GO:0042744) | 2.73765089 |
| 114 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 2.73526143 |
| 115 | phagosome maturation (GO:0090382) | 2.73369950 |
| 116 | mitochondrial calcium ion transport (GO:0006851) | 2.72443085 |
| 117 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71800938 |
| 118 | deoxyribose phosphate catabolic process (GO:0046386) | 2.71698802 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 2.71324805 |
| 120 | metallo-sulfur cluster assembly (GO:0031163) | 2.70879153 |
| 121 | iron-sulfur cluster assembly (GO:0016226) | 2.70879153 |
| 122 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.70756488 |
| 123 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.70586408 |
| 124 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.70129403 |
| 125 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69695895 |
| 126 | aromatic amino acid family metabolic process (GO:0009072) | 2.69622088 |
| 127 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.69583329 |
| 128 | tryptophan catabolic process (GO:0006569) | 2.68697427 |
| 129 | indole-containing compound catabolic process (GO:0042436) | 2.68697427 |
| 130 | indolalkylamine catabolic process (GO:0046218) | 2.68697427 |
| 131 | peptidyl-histidine modification (GO:0018202) | 2.68121815 |
| 132 | virion assembly (GO:0019068) | 2.68001226 |
| 133 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67216070 |
| 134 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67216070 |
| 135 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.66816382 |
| 136 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.66734492 |
| 137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.66734492 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.66734492 |
| 139 | fructose metabolic process (GO:0006000) | 2.66209961 |
| 140 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.65926182 |
| 141 | protein complex disassembly (GO:0043241) | 2.65359015 |
| 142 | protein complex biogenesis (GO:0070271) | 2.65029974 |
| 143 | NADH metabolic process (GO:0006734) | 2.64900508 |
| 144 | kynurenine metabolic process (GO:0070189) | 2.64817981 |
| 145 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.64370855 |
| 146 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.64370855 |
| 147 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.63912630 |
| 148 | respiratory chain complex IV assembly (GO:0008535) | 2.62960478 |
| 149 | regulation of cellular respiration (GO:0043457) | 2.62726617 |
| 150 | tryptophan metabolic process (GO:0006568) | 2.62413722 |
| 151 | pyrimidine-containing compound biosynthetic process (GO:0072528) | 2.61932836 |
| 152 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.61569988 |
| 153 | folic acid transport (GO:0015884) | 2.61282796 |
| 154 | glyoxylate metabolic process (GO:0046487) | 2.61091818 |
| 155 | * fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.60706373 |
| 156 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.60286978 |
| 157 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 2.60265845 |
| 158 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.59926187 |
| 159 | cellular metabolic compound salvage (GO:0043094) | 2.59664408 |
| 160 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.59413340 |
| 161 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.59392695 |
| 162 | cellular component biogenesis (GO:0044085) | 2.59372475 |
| 163 | cytochrome complex assembly (GO:0017004) | 2.59136848 |
| 164 | negative regulation of ligase activity (GO:0051352) | 2.58429592 |
| 165 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.58429592 |
| 166 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.57211642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84096815 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.33005771 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.21737741 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11709517 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.09350185 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.93707459 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.77166330 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68210512 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61419555 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.59991004 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59377503 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50483424 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49731355 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.43972317 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27914390 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.21758504 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.14704290 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.13846528 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07948381 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04596224 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02197804 |
| 22 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01768070 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.01378143 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.00673038 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00015398 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98091902 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96564978 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96290216 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.92289845 |
| 30 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84753931 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82494986 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82151663 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81941363 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.81893781 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79856183 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79842724 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77613049 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76343246 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75313489 |
| 40 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.73258092 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71642771 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71352559 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70925719 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67889358 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66947898 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65113846 |
| 47 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.64186580 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62202354 |
| 49 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59987853 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56086834 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55925440 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49800876 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48010969 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45552530 |
| 55 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42970990 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41833781 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39998920 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39267763 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39134551 |
| 60 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38947788 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38270262 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.37445060 |
| 63 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36965761 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33812479 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32893751 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.32118431 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31699580 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31508525 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29589701 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27620274 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25161042 |
| 72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23958074 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22282324 |
| 74 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.22260928 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22253104 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22189371 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21163108 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20913795 |
| 79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18905524 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18231280 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17425701 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17075548 |
| 83 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16910646 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16445029 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14972907 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14922328 |
| 87 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14103854 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13021690 |
| 89 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12971207 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12145161 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.11976879 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11619719 |
| 93 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10727076 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08577120 |
| 95 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08421917 |
| 96 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08184370 |
| 97 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07883855 |
| 98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06359675 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06243153 |
| 100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06211408 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06076029 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05904061 |
| 103 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05612132 |
| 104 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05507676 |
| 105 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04801258 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04797272 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04433575 |
| 108 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03532835 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03482214 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 1.02439334 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02379118 |
| 112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01490498 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01453042 |
| 114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01009326 |
| 115 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00649320 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00573458 |
| 117 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00481809 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00266877 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99584331 |
| 120 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99340511 |
| 121 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98249624 |
| 122 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96709700 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94369459 |
| 124 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94116330 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92461126 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92133030 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91655657 |
| 128 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90270601 |
| 129 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90206891 |
| 130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89291558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.41279468 |
| 2 | MP0005360_urolithiasis | 4.34333923 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.32095101 |
| 4 | MP0003693_abnormal_embryo_hatching | 4.11773417 |
| 5 | MP0000372_irregular_coat_pigmentation | 3.66734633 |
| 6 | MP0009840_abnormal_foam_cell | 3.20820359 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.08822754 |
| 8 | MP0005365_abnormal_bile_salt | 3.06979034 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 2.73185221 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55211833 |
| 11 | MP0003186_abnormal_redox_activity | 2.34261464 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.33976699 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.22481629 |
| 14 | MP0005332_abnormal_amino_acid | 2.20979870 |
| 15 | MP0000751_myopathy | 2.14917296 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.05488939 |
| 17 | MP0009697_abnormal_copulation | 2.05421066 |
| 18 | MP0000749_muscle_degeneration | 2.03580297 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.00391846 |
| 20 | MP0004510_myositis | 1.95368534 |
| 21 | MP0003136_yellow_coat_color | 1.94843936 |
| 22 | MP0000750_abnormal_muscle_regeneration | 1.94135818 |
| 23 | MP0005423_abnormal_somatic_nervous | 1.90237791 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.89088525 |
| 25 | MP0001764_abnormal_homeostasis | 1.86833812 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 1.84902361 |
| 27 | MP0009785_altered_susceptibility_to | 1.78108123 |
| 28 | MP0003436_decreased_susceptibility_to | 1.77189357 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.73852472 |
| 30 | MP0002822_catalepsy | 1.71556449 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.70823699 |
| 32 | MP0004147_increased_porphyrin_level | 1.67420173 |
| 33 | MP0003646_muscle_fatigue | 1.67303989 |
| 34 | MP0003866_abnormal_defecation | 1.64402221 |
| 35 | MP0005083_abnormal_biliary_tract | 1.63655391 |
| 36 | MP0000685_abnormal_immune_system | 1.60477787 |
| 37 | MP0004270_analgesia | 1.59739127 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.59051228 |
| 39 | MP0009379_abnormal_foot_pigmentation | 1.56276213 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.55604516 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.54506564 |
| 42 | MP0003075_altered_response_to | 1.53908522 |
| 43 | MP0000609_abnormal_liver_physiology | 1.53452911 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.53342128 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.52547953 |
| 46 | MP0005025_abnormal_response_to | 1.50062706 |
| 47 | MP0001529_abnormal_vocalization | 1.47506168 |
| 48 | MP0003724_increased_susceptibility_to | 1.46606681 |
| 49 | MP0000747_muscle_weakness | 1.45474675 |
| 50 | MP0003123_paternal_imprinting | 1.44404035 |
| 51 | MP0005330_cardiomyopathy | 1.43735653 |
| 52 | MP0010094_abnormal_chromosome_stability | 1.42777192 |
| 53 | MP0001853_heart_inflammation | 1.42773703 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.41593151 |
| 55 | MP0003077_abnormal_cell_cycle | 1.40423302 |
| 56 | MP0008469_abnormal_protein_level | 1.38754903 |
| 57 | MP0005671_abnormal_response_to | 1.38623960 |
| 58 | MP0003718_maternal_effect | 1.38397125 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.38325188 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.37998302 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.35660094 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.35343297 |
| 63 | MP0000358_abnormal_cell_content/ | 1.28340161 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.28167565 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28164839 |
| 66 | MP0002419_abnormal_innate_immunity | 1.27188275 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 1.26966031 |
| 68 | MP0001800_abnormal_humoral_immune | 1.25850010 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.22877549 |
| 70 | MP0002723_abnormal_immune_serum | 1.22737912 |
| 71 | MP0002106_abnormal_muscle_physiology | 1.21103783 |
| 72 | MP0001756_abnormal_urination | 1.19130897 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.18115234 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.17413018 |
| 75 | MP0000343_altered_response_to | 1.15747340 |
| 76 | MP0008995_early_reproductive_senescence | 1.15318604 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.15281336 |
| 78 | MP0003195_calcinosis | 1.13734324 |
| 79 | MP0002452_abnormal_antigen_presenting | 1.13339790 |
| 80 | MP0005408_hypopigmentation | 1.12553382 |
| 81 | MP0001819_abnormal_immune_cell | 1.12405427 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.12052386 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.11633691 |
| 84 | MP0002332_abnormal_exercise_endurance | 1.11250165 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.10329074 |
| 86 | MP0002398_abnormal_bone_marrow | 1.09479423 |
| 87 | MP0005165_increased_susceptibility_to | 1.08847234 |
| 88 | MP0000490_abnormal_crypts_of | 1.08721861 |
| 89 | MP0002722_abnormal_immune_system | 1.08572666 |
| 90 | MP0003183_abnormal_peptide_metabolism | 1.08217509 |
| 91 | MP0006082_CNS_inflammation | 1.07895724 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.07845513 |
| 93 | MP0008932_abnormal_embryonic_tissue | 1.07772596 |
| 94 | MP0002653_abnormal_ependyma_morphology | 1.07553622 |
| 95 | MP0003252_abnormal_bile_duct | 1.07058559 |
| 96 | MP0000716_abnormal_immune_system | 1.04725610 |
| 97 | MP0002429_abnormal_blood_cell | 1.04263034 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 1.03485499 |
| 99 | MP0003763_abnormal_thymus_physiology | 1.02828756 |
| 100 | MP0001661_extended_life_span | 1.02000666 |
| 101 | MP0003172_abnormal_lysosome_physiology | 1.01740026 |
| 102 | MP0002019_abnormal_tumor_incidence | 1.00720889 |
| 103 | MP0005451_abnormal_body_composition | 1.00135875 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.99220314 |
| 105 | MP0005397_hematopoietic_system_phenotyp | 0.99220314 |
| 106 | MP0005387_immune_system_phenotype | 0.98885678 |
| 107 | MP0001790_abnormal_immune_system | 0.98885678 |
| 108 | MP0000598_abnormal_liver_morphology | 0.98037837 |
| 109 | MP0008004_abnormal_stomach_pH | 0.97986276 |
| 110 | MP0008260_abnormal_autophagy | 0.97767139 |
| 111 | MP0009764_decreased_sensitivity_to | 0.97648515 |
| 112 | MP0002735_abnormal_chemical_nociception | 0.97467897 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.97092409 |
| 114 | MP0002405_respiratory_system_inflammati | 0.95225142 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.92762145 |
| 116 | MP0003329_amyloid_beta_deposits | 0.91826083 |
| 117 | MP0009763_increased_sensitivity_to | 0.91580289 |
| 118 | MP0000858_altered_metastatic_potential | 0.90988227 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.90352831 |
| 120 | MP0008058_abnormal_DNA_repair | 0.90315023 |
| 121 | MP0005166_decreased_susceptibility_to | 0.90121156 |
| 122 | MP0008873_increased_physiological_sensi | 0.89900127 |
| 123 | MP0008872_abnormal_physiological_respon | 0.87816177 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.87346947 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.85393008 |
| 126 | MP0002064_seizures | 0.85207988 |
| 127 | MP0008874_decreased_physiological_sensi | 0.84952811 |
| 128 | MP0001730_embryonic_growth_arrest | 0.84761217 |
| 129 | MP0002132_abnormal_respiratory_system | 0.84585648 |
| 130 | MP0001849_ear_inflammation | 0.83881167 |
| 131 | MP0003786_premature_aging | 0.82861431 |
| 132 | MP0003879_abnormal_hair_cell | 0.80108314 |
| 133 | MP0005670_abnormal_white_adipose | 0.79857585 |
| 134 | MP0002090_abnormal_vision | 0.79166765 |
| 135 | MP0000604_amyloidosis | 0.79049271 |
| 136 | MP0002095_abnormal_skin_pigmentation | 0.78961873 |
| 137 | MP0001188_hyperpigmentation | 0.78821150 |
| 138 | MP0002138_abnormal_hepatobiliary_system | 0.78740569 |
| 139 | MP0008007_abnormal_cellular_replicative | 0.78692463 |
| 140 | MP0003011_delayed_dark_adaptation | 0.78597964 |
| 141 | MP0009046_muscle_twitch | 0.77478572 |
| 142 | MP0001905_abnormal_dopamine_level | 0.77229641 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.77003015 |
| 144 | MP0001970_abnormal_pain_threshold | 0.76232429 |
| 145 | MP0002163_abnormal_gland_morphology | 0.75946152 |
| 146 | MP0005266_abnormal_metabolism | 0.74003042 |
| 147 | MP0002972_abnormal_cardiac_muscle | 0.73287658 |
| 148 | MP0001873_stomach_inflammation | 0.71667378 |
| 149 | MP0008569_lethality_at_weaning | 0.70471407 |
| 150 | MP0004142_abnormal_muscle_tone | 0.70443625 |
| 151 | MP0005501_abnormal_skin_physiology | 0.69043340 |
| 152 | MP0008789_abnormal_olfactory_epithelium | 0.68292049 |
| 153 | MP0005369_muscle_phenotype | 0.66722823 |
| 154 | MP0002734_abnormal_mechanical_nocicepti | 0.66218111 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.65973750 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.65431885 |
| 157 | MP0002269_muscular_atrophy | 0.63333615 |
| 158 | MP0004036_abnormal_muscle_relaxation | 0.59902918 |
| 159 | MP0002733_abnormal_thermal_nociception | 0.58599981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Conjugated hyperbilirubinemia (HP:0002908) | 5.91949995 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.48064257 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.43638811 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 5.20672053 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.10338323 |
| 6 | Abnormal gallbladder physiology (HP:0012438) | 4.73904120 |
| 7 | Cholecystitis (HP:0001082) | 4.73904120 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.20022129 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.96876134 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.66865125 |
| 11 | Abnormality of glycolysis (HP:0004366) | 3.62375915 |
| 12 | Hepatic necrosis (HP:0002605) | 3.44892186 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.40860237 |
| 14 | Multiple enchondromatosis (HP:0005701) | 3.39891728 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.36297691 |
| 16 | Exercise intolerance (HP:0003546) | 3.35452097 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.31799381 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.23001686 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.17229985 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.14482914 |
| 21 | Popliteal pterygium (HP:0009756) | 3.14046136 |
| 22 | Hyperglycinuria (HP:0003108) | 3.13278556 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.12432973 |
| 24 | Abnormal number of erythroid precursors (HP:0012131) | 3.11953703 |
| 25 | Respiratory failure (HP:0002878) | 3.08372118 |
| 26 | Ragged-red muscle fibers (HP:0003200) | 3.04967516 |
| 27 | Rhabdomyolysis (HP:0003201) | 3.03618733 |
| 28 | Hyperbilirubinemia (HP:0002904) | 2.90280481 |
| 29 | Spastic paraparesis (HP:0002313) | 2.81832411 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.79909596 |
| 31 | Distal lower limb muscle weakness (HP:0009053) | 2.74036360 |
| 32 | Rough bone trabeculation (HP:0100670) | 2.73282557 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 2.67396633 |
| 34 | Myokymia (HP:0002411) | 2.66963770 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.66276583 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.66276583 |
| 37 | Macrocytic anemia (HP:0001972) | 2.63969779 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63511473 |
| 39 | Cholelithiasis (HP:0001081) | 2.62532344 |
| 40 | Respiratory difficulties (HP:0002880) | 2.59838698 |
| 41 | Xanthomatosis (HP:0000991) | 2.58756904 |
| 42 | Hyperglycinemia (HP:0002154) | 2.56593073 |
| 43 | Hyperammonemia (HP:0001987) | 2.55957370 |
| 44 | IgM deficiency (HP:0002850) | 2.53836819 |
| 45 | Opisthotonus (HP:0002179) | 2.53008391 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49894113 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.49894113 |
| 48 | Purpura (HP:0000979) | 2.49818928 |
| 49 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48068577 |
| 50 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46347035 |
| 51 | Aplastic anemia (HP:0001915) | 2.41065566 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39977949 |
| 53 | Mitochondrial inheritance (HP:0001427) | 2.37422957 |
| 54 | Lethargy (HP:0001254) | 2.35140124 |
| 55 | Myopathic facies (HP:0002058) | 2.33661656 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.33618198 |
| 57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.33618198 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33341308 |
| 59 | Short nail (HP:0001799) | 2.32895238 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.32649827 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.30192655 |
| 62 | Thrombocytosis (HP:0001894) | 2.29969489 |
| 63 | 3-Methylglutaconic aciduria (HP:0003535) | 2.28836816 |
| 64 | Abnormality of methionine metabolism (HP:0010901) | 2.26428527 |
| 65 | Leukodystrophy (HP:0002415) | 2.26125130 |
| 66 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25977863 |
| 67 | X-linked dominant inheritance (HP:0001423) | 2.25144117 |
| 68 | Nemaline bodies (HP:0003798) | 2.24754596 |
| 69 | Increased CSF lactate (HP:0002490) | 2.23905676 |
| 70 | Increased serum lactate (HP:0002151) | 2.23716217 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 2.22803565 |
| 72 | Pallor (HP:0000980) | 2.22123558 |
| 73 | Reticulocytopenia (HP:0001896) | 2.21007058 |
| 74 | Ketosis (HP:0001946) | 2.20347154 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19350794 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18351679 |
| 77 | Abnormality of the preputium (HP:0100587) | 2.18106315 |
| 78 | Deep venous thrombosis (HP:0002625) | 2.17761256 |
| 79 | Hypoglycemic coma (HP:0001325) | 2.17534287 |
| 80 | CNS demyelination (HP:0007305) | 2.15604938 |
| 81 | Abnormal trabecular bone morphology (HP:0100671) | 2.15580896 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.15479301 |
| 83 | Late onset (HP:0003584) | 2.15129958 |
| 84 | Cerebral palsy (HP:0100021) | 2.14878330 |
| 85 | Cerebral edema (HP:0002181) | 2.12934020 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.12462086 |
| 87 | Mutism (HP:0002300) | 2.12268474 |
| 88 | Muscle fiber splitting (HP:0003555) | 2.12250328 |
| 89 | Muscle fiber inclusion bodies (HP:0100299) | 2.10689022 |
| 90 | Gout (HP:0001997) | 2.08663319 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.08366501 |
| 92 | Ankle clonus (HP:0011448) | 2.08130209 |
| 93 | Megaloblastic anemia (HP:0001889) | 2.07992903 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07402365 |
| 95 | Abnormal hemoglobin (HP:0011902) | 2.07391101 |
| 96 | Entropion (HP:0000621) | 2.07289847 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 2.07143954 |
| 98 | Poikiloderma (HP:0001029) | 2.06896693 |
| 99 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.06815209 |
| 100 | Oral leukoplakia (HP:0002745) | 2.06124627 |
| 101 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03755305 |
| 102 | Hypolipoproteinemia (HP:0010981) | 2.03008996 |
| 103 | Abnormal platelet function (HP:0011869) | 2.02929815 |
| 104 | Impaired platelet aggregation (HP:0003540) | 2.02929815 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.02544051 |
| 106 | Delusions (HP:0000746) | 2.02426925 |
| 107 | Recurrent bacterial skin infections (HP:0005406) | 2.01331934 |
| 108 | Fat malabsorption (HP:0002630) | 2.01173562 |
| 109 | Petechiae (HP:0000967) | 2.00727142 |
| 110 | Poor head control (HP:0002421) | 2.00718764 |
| 111 | Oligomenorrhea (HP:0000876) | 1.98693338 |
| 112 | Gliosis (HP:0002171) | 1.97850458 |
| 113 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97743450 |
| 114 | Abnormality of macrophages (HP:0004311) | 1.96989730 |
| 115 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96756266 |
| 116 | Methylmalonic aciduria (HP:0012120) | 1.96691655 |
| 117 | Exertional dyspnea (HP:0002875) | 1.96559736 |
| 118 | Myoglobinuria (HP:0002913) | 1.96367139 |
| 119 | Death in childhood (HP:0003819) | 1.94529057 |
| 120 | Recurrent abscess formation (HP:0002722) | 1.94006398 |
| 121 | Optic disc pallor (HP:0000543) | 1.93910735 |
| 122 | Lactic acidosis (HP:0003128) | 1.93519548 |
| 123 | Mesangial abnormality (HP:0001966) | 1.93232105 |
| 124 | Deformed sella turcica (HP:0002681) | 1.91586743 |
| 125 | Fair hair (HP:0002286) | 1.91164627 |
| 126 | Acute encephalopathy (HP:0006846) | 1.89798108 |
| 127 | Metabolic acidosis (HP:0001942) | 1.89108127 |
| 128 | Eczematoid dermatitis (HP:0000976) | 1.89018419 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.88307653 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.87930030 |
| 131 | Emotional lability (HP:0000712) | 1.86686808 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 1.85981294 |
| 133 | Glycosuria (HP:0003076) | 1.85981294 |
| 134 | Abnormality of the anterior horn cell (HP:0006802) | 1.85363980 |
| 135 | Degeneration of anterior horn cells (HP:0002398) | 1.85363980 |
| 136 | Meckel diverticulum (HP:0002245) | 1.84644447 |
| 137 | Patellar aplasia (HP:0006443) | 1.83583982 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.83582621 |
| 139 | Athetosis (HP:0002305) | 1.82131385 |
| 140 | Nausea (HP:0002018) | 1.82091705 |
| 141 | Microretrognathia (HP:0000308) | 1.81706561 |
| 142 | Increased muscle lipid content (HP:0009058) | 1.81556488 |
| 143 | Paraparesis (HP:0002385) | 1.81075644 |
| 144 | Abnormality of serum amino acid levels (HP:0003112) | 1.80860112 |
| 145 | Cerebral hypomyelination (HP:0006808) | 1.80514452 |
| 146 | Hypokinesia (HP:0002375) | 1.80161140 |
| 147 | Joint hemorrhage (HP:0005261) | 1.79663004 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.79571564 |
| 149 | Muscle fibrillation (HP:0010546) | 1.79262850 |
| 150 | Fasciculations (HP:0002380) | 1.76583263 |
| 151 | Severe visual impairment (HP:0001141) | 1.76381671 |
| 152 | Visual hallucinations (HP:0002367) | 1.76077465 |
| 153 | Neuronal loss in central nervous system (HP:0002529) | 1.75285822 |
| 154 | Tongue fasciculations (HP:0001308) | 1.74200471 |
| 155 | Microvesicular hepatic steatosis (HP:0001414) | 1.74123317 |
| 156 | Increased serum ferritin (HP:0003281) | 1.71834241 |
| 157 | Exercise-induced muscle cramps (HP:0003710) | 1.68240280 |
| 158 | Growth hormone excess (HP:0000845) | 1.67749719 |
| 159 | Polyphagia (HP:0002591) | 1.67111914 |
| 160 | Axonal loss (HP:0003447) | 1.66364433 |
| 161 | Muscle stiffness (HP:0003552) | 1.66083523 |
| 162 | Large for gestational age (HP:0001520) | 1.65956084 |
| 163 | Prolonged bleeding time (HP:0003010) | 1.65541938 |
| 164 | Loss of speech (HP:0002371) | 1.64745641 |
| 165 | Obstructive lung disease (HP:0006536) | 1.64566570 |
| 166 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64566570 |
| 167 | Dysostosis multiplex (HP:0000943) | 1.64358221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 6.23859972 |
| 2 | VRK2 | 4.47124180 |
| 3 | BUB1 | 4.35010428 |
| 4 | PIM2 | 3.78567456 |
| 5 | GRK5 | 2.99335811 |
| 6 | NME1 | 2.87053921 |
| 7 | BCKDK | 2.54137848 |
| 8 | WEE1 | 2.46607840 |
| 9 | CDK19 | 2.32718364 |
| 10 | PRKD3 | 2.30258287 |
| 11 | TESK2 | 2.29701080 |
| 12 | STK16 | 2.28731270 |
| 13 | MAPKAPK3 | 2.21954349 |
| 14 | SRPK1 | 2.13562512 |
| 15 | BRSK2 | 2.13481969 |
| 16 | ARAF | 2.01075733 |
| 17 | MAP4K1 | 1.90529381 |
| 18 | TESK1 | 1.85645023 |
| 19 | RPS6KB2 | 1.75337926 |
| 20 | TAOK2 | 1.74650516 |
| 21 | MAP3K12 | 1.71587059 |
| 22 | CAMKK2 | 1.53990022 |
| 23 | ZAP70 | 1.49888059 |
| 24 | KDR | 1.48379198 |
| 25 | PHKG1 | 1.47486210 |
| 26 | PHKG2 | 1.47486210 |
| 27 | EIF2AK3 | 1.45369338 |
| 28 | IRAK3 | 1.43314406 |
| 29 | EPHA2 | 1.41281432 |
| 30 | TSSK6 | 1.40313755 |
| 31 | ILK | 1.38593189 |
| 32 | PRPF4B | 1.37817603 |
| 33 | FLT3 | 1.32231233 |
| 34 | EIF2AK1 | 1.31551695 |
| 35 | MAP3K11 | 1.30046801 |
| 36 | MAP3K6 | 1.27628188 |
| 37 | PAK6 | 1.26951760 |
| 38 | BRSK1 | 1.25990388 |
| 39 | TYK2 | 1.25476119 |
| 40 | ACVR1B | 1.21059411 |
| 41 | ERN1 | 1.19825899 |
| 42 | LMTK2 | 1.14455003 |
| 43 | ZAK | 1.13902785 |
| 44 | RIPK4 | 1.10297435 |
| 45 | IRAK4 | 1.08719659 |
| 46 | LIMK1 | 1.08499697 |
| 47 | MUSK | 1.08458693 |
| 48 | OBSCN | 1.07878699 |
| 49 | BTK | 1.06836302 |
| 50 | PBK | 1.05256610 |
| 51 | TEC | 1.04653729 |
| 52 | GRK6 | 1.03965155 |
| 53 | PRKG2 | 1.00243047 |
| 54 | PIM1 | 0.99509879 |
| 55 | VRK1 | 0.99028515 |
| 56 | ABL2 | 0.99000274 |
| 57 | CSNK1G3 | 0.97067502 |
| 58 | DAPK1 | 0.96028450 |
| 59 | MAP2K3 | 0.95769388 |
| 60 | TBK1 | 0.94874537 |
| 61 | LRRK2 | 0.93064233 |
| 62 | SMG1 | 0.87752066 |
| 63 | KIT | 0.84360232 |
| 64 | AURKA | 0.80803673 |
| 65 | BRAF | 0.79584062 |
| 66 | PKN2 | 0.78851529 |
| 67 | BMX | 0.76496908 |
| 68 | TNK2 | 0.75890264 |
| 69 | TLK1 | 0.73325712 |
| 70 | CAMK2G | 0.73314256 |
| 71 | NEK2 | 0.72870655 |
| 72 | CSNK1A1L | 0.72240102 |
| 73 | BLK | 0.72093716 |
| 74 | PLK4 | 0.70933894 |
| 75 | CDK8 | 0.69932775 |
| 76 | AKT3 | 0.69329112 |
| 77 | TXK | 0.68684496 |
| 78 | NEK1 | 0.68346549 |
| 79 | SCYL2 | 0.67763200 |
| 80 | PAK4 | 0.65965050 |
| 81 | DAPK3 | 0.65867153 |
| 82 | TIE1 | 0.65358674 |
| 83 | MST4 | 0.65260848 |
| 84 | RAF1 | 0.65250207 |
| 85 | DYRK2 | 0.65191785 |
| 86 | RPS6KA5 | 0.64595166 |
| 87 | SYK | 0.62368273 |
| 88 | STK10 | 0.60884101 |
| 89 | MAP2K7 | 0.60846891 |
| 90 | CSNK1G2 | 0.60803445 |
| 91 | AKT2 | 0.60675100 |
| 92 | TRIB3 | 0.60657430 |
| 93 | MAPK12 | 0.58378246 |
| 94 | MAP3K3 | 0.58146915 |
| 95 | LYN | 0.56893416 |
| 96 | MATK | 0.55471864 |
| 97 | CSNK1G1 | 0.53718825 |
| 98 | PIK3CG | 0.53017545 |
| 99 | IKBKB | 0.52622116 |
| 100 | AURKB | 0.52375419 |
| 101 | PLK1 | 0.51328622 |
| 102 | DAPK2 | 0.50516031 |
| 103 | TAOK3 | 0.50133956 |
| 104 | CAMK2D | 0.49905488 |
| 105 | CDK14 | 0.49486426 |
| 106 | PKN1 | 0.49152949 |
| 107 | STK24 | 0.46819673 |
| 108 | DYRK3 | 0.46027005 |
| 109 | MAPK4 | 0.45465621 |
| 110 | PAK1 | 0.44124590 |
| 111 | PRKD1 | 0.43751838 |
| 112 | PASK | 0.43063199 |
| 113 | IKBKE | 0.42371056 |
| 114 | MYLK | 0.42216391 |
| 115 | TAOK1 | 0.41991885 |
| 116 | IRAK1 | 0.41444372 |
| 117 | PTK2B | 0.40868290 |
| 118 | CDK7 | 0.39976368 |
| 119 | DYRK1B | 0.39738219 |
| 120 | MAP2K6 | 0.39619153 |
| 121 | KSR2 | 0.38160103 |
| 122 | CSNK2A1 | 0.38057241 |
| 123 | CSF1R | 0.37895139 |
| 124 | PRKCI | 0.37867550 |
| 125 | EEF2K | 0.36436764 |
| 126 | CAMKK1 | 0.36045104 |
| 127 | JAK2 | 0.35373704 |
| 128 | MAP3K1 | 0.35236799 |
| 129 | EPHB1 | 0.34592056 |
| 130 | CDK11A | 0.34497734 |
| 131 | MST1R | 0.33800220 |
| 132 | CCNB1 | 0.33715750 |
| 133 | MARK2 | 0.33113094 |
| 134 | TTN | 0.32714615 |
| 135 | CSNK2A2 | 0.32587246 |
| 136 | ATR | 0.32178919 |
| 137 | MAPK11 | 0.30461064 |
| 138 | HIPK2 | 0.30081343 |
| 139 | CSK | 0.29328323 |
| 140 | MINK1 | 0.29038643 |
| 141 | SIK3 | 0.28758315 |
| 142 | PRKCD | 0.28750772 |
| 143 | FGFR4 | 0.28688480 |
| 144 | MAP3K8 | 0.28624039 |
| 145 | MAP3K5 | 0.28295367 |
| 146 | SIK1 | 0.27731100 |
| 147 | PDK2 | 0.26479061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.66881267 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.88687044 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.62102561 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.56239928 |
| 5 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.33344305 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.28981465 |
| 7 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15899202 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.04591616 |
| 9 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.03280725 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.99569852 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.96415923 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82894688 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81587063 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.79177166 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.77254748 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74984063 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.73524205 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70830474 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69927535 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.67501957 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.64410331 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62736997 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.62447184 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.56532704 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56044212 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.55944794 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55257197 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53252845 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48763658 |
| 30 | * Peroxisome_Homo sapiens_hsa04146 | 1.47220119 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46884082 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46830638 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44928560 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41387238 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39959595 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38413843 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35163853 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33583966 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31411766 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30928469 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.29954378 |
| 42 | Mismatch repair_Homo sapiens_hsa03430 | 1.28255900 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27066628 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.25785242 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25344236 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24910113 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22811224 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21834700 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20382123 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17171042 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15253080 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12103475 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 1.11278013 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 1.10538048 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09596206 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06876848 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 1.03780610 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02094298 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01144696 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95655358 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94747752 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94547644 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92840619 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89929725 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88962704 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87673323 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.87215560 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84644211 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84542206 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84460878 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82921134 |
| 72 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.82632621 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82188137 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81894159 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80460310 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80101983 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79718370 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79043746 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76881591 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76337959 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74497932 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73119486 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71166952 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69808153 |
| 85 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69072379 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68268846 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67487454 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66740363 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.66176780 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66116067 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65908464 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.63767332 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59736052 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.58529172 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58201358 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57154545 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56129614 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55997165 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54478006 |
| 100 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53423304 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.49229186 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.47735670 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.47188201 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.46735806 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46256264 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46222549 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.45074537 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45048005 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43135585 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41436161 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39685925 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35837878 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34518754 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33184734 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32646998 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32347369 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30565374 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.29709022 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26701965 |
| 120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24187446 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.22061620 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.19960006 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.18406738 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16664275 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12154336 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.05196547 |

